Los Angeles Capital Management’s Veracyte VCYT Stock Holding History
Bought
Maintained
Sold
Other funds holding VCYT
VPM
VCM
AIM
Los Angeles Capital Management's VCYT Position: Q1 2026 in Review
Los Angeles Capital Management increased its Veracyte (VCYT) stake by 66% in Q1 2026, buying an estimated $1.35M and bringing the position to 91,401 shares worth $2.94M. The position accounts for 0.01% of the portfolio, ranked #423.
Los Angeles Capital Management first reported a position in VCYT in Q4 2018 and has held it in 19 quarters since. 334 funds tracked by Wall St. Rank hold VCYT as of Q1 2026.
- Los Angeles Capital Management held 91,401 shares of Veracyte worth $2.94M as of Q1 2026.
- Los Angeles Capital Management bought 36,357 Veracyte shares in Q1 2026, an estimated $1.35M.
- Veracyte made up 0.01% of Los Angeles Capital Management's portfolio in Q1 2026, its #423 holding.
- Los Angeles Capital Management first reported a position in Veracyte in Q4 2018 and has held it in 19 quarters since.
- 334 funds tracked by Wall St. Rank held Veracyte as of Q1 2026.
Based on Los Angeles Capital Management's 13F filing for Q1 2026, filed 8 May 2026.